STOCK TITAN

Aeluma (ALMU) SEC Filings, Sep-Nov 2025

ALMU NASDAQ

Aeluma, Inc. filings document the reporting record of a Nasdaq-listed emerging growth semiconductor company developing scalable photonic and electronic technologies. Its periodic and current reports cover financial results, quarterly reporting, Regulation FD materials, investor presentations and public-company disclosure controls.

The company’s SEC filings also describe capital-structure activity involving common stock, shelf registration, underwriting agreements and sales-agreement arrangements for registered equity issuance. Governance disclosures include annual meeting voting results, director elections and shareholder approvals, while other current reports address material definitive agreements and Rule 10b5-1 trading-plan disclosures.

Rhea-AI Summary

Aeluma, Inc. filed Post‑Effective Amendment No. 5 to its Form S‑1, covering the resale of up to 11,010,002 shares of Common Stock by selling stockholders. The company states it will not receive proceeds from these resales. Under “Use of Proceeds,” Aeluma notes it could receive cash only if Placement Agent Warrants are exercised, with gross proceeds of up to $720,000.

This amendment also updates mechanics around effectiveness under Section 8(a) and files Exhibit 23.1; no additional securities are being registered and fees were previously paid. The Nasdaq Capital Market lists ALMU; the last reported sales price was $15.58 per share as of October 30, 2025. The resale pool includes shares issued in prior offerings, merger-related issuances, pre‑merger holdings, and shares issuable upon warrant exercise, as detailed in “The Offering.”

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
amendment
-
Rhea-AI Summary

Aeluma (ALMU) insider activity: A reporting person disclosed open-market sales of common stock. On 10/17/2025, sales totaled 33,344 shares at a weighted average price of $16.75, 5,913 shares at $17.77, and 743 shares at $18.45. On 10/20/2025, an additional 37,500 shares were sold at $16.39. The prices reflect weighted averages across multiple trades within disclosed ranges.

Following these transactions, the reporting person beneficially owned 2,319,988 shares, held directly. The filer is identified as a Director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.87%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) filed an 8-K under Item 8.01 to furnish its new investor PowerPoint presentation as Exhibit 99.1. The company also included the standard legend stating the report and exhibit do not constitute an offer to sell or a solicitation to buy securities in any jurisdiction prior to proper registration or qualification. The filing lists the company’s common stock trading on Nasdaq under the symbol ALMU.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.40%
Tags
current report
Rhea-AI Summary

Aeluma, Inc. (ALMU) director reported open‑market sales of common stock on 10/15/2025 and 10/16/2025 (transaction code S). On 10/15/2025, sales included 24,147 shares at $20.11 (weighted average) and 15,853 shares at $21.31. On 10/16/2025, sales included 17,540 shares at $18.97, 6,650 shares at $19.96, and 810 shares at $20.72. Following these trades, the reporting person beneficially owns 2,397,488 shares, held directly. Footnotes note weighted‑average pricing across stated ranges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.40%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) reported insider share sales on a Form 4. The reporting person executed multiple open‑market sales of common stock: 30,587 shares at a weighted average price of $16.60 on 10/10/2025 (range $16.06–$17.05), an additional 4,413 shares at $17.16 on 10/10/2025 (range $17.06–$17.25), 35,031 shares at $16.97 on 10/13/2025 (range $16.53–$17.49), 300 shares at $17.57 on 10/13/2025, and 36,855 shares at $19.86 on 10/14/2025 (range $19.65–$20.32). After these transactions, the reporting person beneficially owned 2,462,488 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.47%
Tags
insider
-
Rhea-AI Summary

Mark N. Tompkins, a director of Aeluma, Inc. (ALMU), reported multiple open-market sales of common stock executed on 10/07/2025 through 10/09/2025.

The filings show a total of 106,908 shares sold across seven transactions at reported weighted-average prices ranging from $16.54 to $19.16, with the reported weighted-average prices for each tranche listed as $17.46, $18.66, $19.16, $17.46, $18.14, and $16.54. Following these sales, the reporting person beneficially owned 2,569,674 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
insider
Rhea-AI Summary

Mark N. Tompkins, a director of Aeluma, Inc. (ALMU), reported multiple sales of common stock across 10/02/2025 to 10/06/2025. The filings show a total of 129,751 shares sold in five transactions at weighted-average prices ranging from $17.10 to $18.70, with per-transaction weighted averages disclosed for each sale. After the reported disposals, the reporting person beneficially owned 2,676,582 shares. The filer certifies willingness to provide detailed price-by-price breakdowns upon request. The form is a routine Section 16 report documenting insider sales; no options or derivative transactions were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.98%
Tags
insider
-
Rhea-AI Summary

Aeluma, Inc. (ALMU) director Mark N. Tompkins amended a prior Form 4 to correct the number of common shares sold and to disclose the weighted average sale price. The amendment shows a sale of 33,800 shares on 09/30/2025 at a weighted average price of $16.18, with the reporter retaining 2,857,033 shares after the transaction. The filing states the shares were sold in multiple transactions at prices ranging from $15.86 to $16.75 and that the amendment fixes a discrepancy in the original October 2 report.

The filing is a technical correction rather than a new transaction disclosure: the reporter affirms willingness to provide details of the per‑trade breakdown on request and manually signed the amendment on 10/06/2025. The disclosure clarifies beneficial ownership and trading price ranges but does not include derivative activity or other material changes to holdings beyond the corrected sale amount.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.98%
Tags
insider
-
Rhea-AI Summary

Mark N. Tompkins, a director of Aeluma, Inc. (ALMU), reported multiple open-market sales of Common Stock dated 09/29/2025 through 10/01/2025. The Form 4 lists six sale transactions: 23,382 shares at a weighted average price of $17.52, 1,618 shares at $18.36, 33,380 shares at $16.18, 200 shares at $17.54, 9,133 shares at $16.39, and 41,367 shares at $16.97. The form shows his beneficial ownership after the reported transactions declining to 2,806,333 shares.

The footnotes disclose the price ranges for each weighted-average sale and the reporting person commits to provide detailed per-price sale information on request. The filing is signed and dated 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.92%
Tags
insider
Rhea-AI Summary

Aeluma, Inc. reported that director Steven DenBaars has terminated a previously adopted Rule 10b5-1 trading plan. The plan, adopted on June 23, 2025, had authorized the potential sale of up to 130,000 shares of Aeluma common stock between October 6, 2025 and May 6, 2026 under preset price and formula conditions. On September 16, 2025, the plan was terminated, and the company stated that no sales were or will be made under this 10b5-1 plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
current report

FAQ

How many Aeluma (ALMU) SEC filings are available on StockTitan?

StockTitan tracks 83 SEC filings for Aeluma (ALMU), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Aeluma (ALMU)?

The most recent SEC filing for Aeluma (ALMU) was filed on November 12, 2026.